Back to last page
Health News
333
HIV / AIDS
| FOSTER CITY, Calif. (AP) -- Gilead Sciences Inc. said Monday that the Food and Drug Administration rejected two marketing applications for HIV treatments, citing quality control problems at the company's manufacturing facilities. WASHINGTON (AP) -- Bad news in the fight against the AIDS virus: The government is halting a large U.S. study of a possible HIV vaccine because the experimental shots aren't preventing infection. | News brought to you by: | | | | | | |
|
Consumer News DMT
dmtICNNews
Consumer News DMT
161404
InteliHealth
1998-05-15
f
InteliHealth
NULL
333, 338, 341, 342, 343, 344, 411, 7087, 7228, 8009, 8010, 8011, 8012, 8013, 8014, 8015, 8895, 8896, 8988, 9247, 9254, 20774, 20775, 20776, 20778, 20779, 20780, 20783, 20785, 20786, 20789, 20792, 20833, 20938, 21142, 21291, 21343, 21344, 21345, 21928, 21961, 22002, 24129, 24524, 24603, 24644, 25491, 25886, 28041, 28042, 28043, 28815, 28918, 29758, 29783, 29796, 29806, 29823, 29834, 29848, 29852, 29861, 29866, 30961, 31307, 31406, 31438, 31464, 32054, 32143, 32212, 35038, 35178, 35428, 48607, 68682, 888341, 888342, 888343,
8013